Interstitial lung diseases

M Wijsenbeek, A Suzuki, TM Maher - The Lancet, 2022 - thelancet.com
Over 200 interstitial lung diseases, from ultra rare to relatively common, are recognised.
Most interstitial lung diseases are characterised by inflammation or fibrosis within the …

The human respiratory microbiome: current understandings and future directions

L Zhao, JL Luo, MK Ali, E Spiekerkoetter… - American journal of …, 2023 - atsjournals.org
Microorganisms colonize the human body. The lungs and respiratory tract, previously
believed to be sterile, harbor diverse microbial communities and the genomes of bacteria …

Evaluation of pulmonary fibrosis outcomes by race and ethnicity in US adults

A Adegunsoye, E Freiheit, EN White, B Kaul… - JAMA network …, 2023 - jamanetwork.com
Importance Pulmonary fibrosis (PF) is characterized by progressive scarring of lung tissue
and poor survival. Racial and ethnic minority populations face the greatest risk of morbidity …

Pharmacotherapy and pulmonary fibrosis risk after SARS-CoV-2 infection: a prospective nationwide cohort study in the United States

A Adegunsoye, R Baccile, TJ Best, V Zaksas… - The Lancet Regional …, 2023 - thelancet.com
Background Pulmonary fibrosis is characterized by lung parenchymal destruction and can
increase morbidity and mortality. Pulmonary fibrosis commonly occurs following …

Pathogenesis, clinical features, and phenotypes of pulmonary hypertension associated with interstitial lung disease: A consensus statement from the Pulmonary …

L Piccari, B Allwood, K Antoniou, JH Chung… - Pulmonary …, 2023 - Wiley Online Library
Pulmonary hypertension (PH) is a frequent complication of interstitial lung disease (ILD).
Although PH has mostly been described in idiopathic pulmonary fibrosis, it can manifest in …

Comparing outcomes of ILD patients managed in specialised versus non-specialised centres

P Marijic, L Schwarzkopf, W Maier, F Trudzinski… - Respiratory …, 2022 - Springer
Background Early appropriate diagnosis and treatment of interstitial lung diseases (ILD) is
crucial to slow disease progression and improve survival. Yet it is unknown whether initial …

Role of circular RNAs in pulmonary fibrosis

J Zhou, Y Chen, M He, X Li, R Wang - International Journal of Molecular …, 2022 - mdpi.com
Pulmonary fibrosis is a chronic progressive form of interstitial lung disease, characterized by
the histopathological pattern of usual interstitial pneumonia. Apart from aberrant alterations …

Autoimmune progressive fibrosing interstitial lung disease: predictors of fast decline

A Nagy, T Nagy, AM Kolonics-Farkas… - Frontiers in …, 2021 - frontiersin.org
A subset of interstitial lung diseases (ILDs) with autoimmune traits—including connective
tissue disease-associated ILD (CTD-ILD) and interstitial pneumonia with autoimmune …

Current perspective of progressive-fibrosing interstitial lung disease

T Kishaba - Respiratory Investigation, 2022 - Elsevier
Interstitial lung disease (ILD) is a parenchymal lung disease and restrictive disorder that
presents as diffuse infiltrative shadows. The initial diagnosis of ILD is important because …

Use of pirfenidone in fibrotic interstitial lung diseases and beyond: a review

M Han, Q Liu, Z Ji, L Jin, W Jin, Z Gao - Frontiers in Medicine, 2024 - frontiersin.org
The pathophysiological mechanisms involved in fibrotic interstitial lung diseases (FILDs) are
akin to those observed in idiopathic pulmonary fibrosis (IPF), implying the potential for …